The risk associated with ADRB1 Gly389 was limited to those without obstructive CAD (n = 400, P interaction = 0.03), albeit marginally significant in this subset (HR 1.71, 95%CI 0.91–3.19).
← all excerpts
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
1
—
—